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Background: Young children with persistent wheezing pose a diagnostic and therapeutical challenge to the
pediatrician.
We aimed to evaluate bacterial bronchial infection as a possible reason for non response to conventional asthma
therapy, and to identify and characterise the predominant pathogens involved.
Methods: We retrospectively analysed microbiological and cytological findings in a selected population of young
wheezers with symptoms unresponsive to inhaled corticosteroid (ICS) therapy, who underwent flexible
bronchoscopy with bronchoalveolar lavage (BAL). Procedural measures were taken to limit contamination risk and
quantitative bacterial culture of BAL fluid (significance cut-off≥ 104 colony-forming units/ml) was used. Modern
microbiological methods were used for detection of a wide panel of pathogens and for characterisation of the
bacterial isolates.
Results: 33 children aged between 4 and 38 months, without structural anomalies of the conductive airways were
evaluated. Significant bacterial BAL cultures were found in 48,5 % of patients. Haemophilus influenzae was isolated
in 30,3 %, Streptococcus pneumoniae in 12,1 % and Moraxella catarrhalis in 12,1 %. All H. influenzae isolates were
non-encapsulated strains and definitely distinguished from non-haemolytic H. haemolyticus. Respiratory viruses were
detected in 21,9 % of cases with mixed bacterial-viral infection in 12,1 %. Cytology revealed a marked neutrophilic
inflammation.
Conclusions: Bacterial infection of the bronchial tree is common in persistent preschool wheezers and provides a
possible explanation for non response to ICS therapy. Non-typeable H. influenzae seems to be the predominant
pathogen involved, followed by S. pneumoniae and M. catarrhalis.
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InfluenzaeBackground
Recurrent and/or persistent wheezing in young children
is a major reason for use of pediatric healthcare
resources [1,2]. Despite the high morbidity of persistent
infantile wheezing, there are only few comprehensive
studies in this domain, resulting in poor knowledge of
the pathophysiology and a lack of efficacy data of* Correspondence: iris.deschutter@uzbrussel.be
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distribution, and reproduction in any mediumtherapeutical interventions [3]. Although 3 pediatric
asthma phenotypes have been described, in daily practice
preschool wheezers remain a diagnostic and therapeutic
challenge to the pediatrician [4,5].
Current asthma guidelines, recommend a trial with
inhaled corticosteroids (ICS) in these children, based on
the established pathophysiology of eosinophilic inflamma-
tion and the proven efficacy in asthma in adults [2,6,7].
From clinical experience and scientific reports, it is ap-
parent that preschool wheezers are a heterogeneous
group of which only part will benefit from the use ofntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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work-up in ICS non-responders, including gastro-
oesophageal reflux and allergy testing, sweat chloride
test and bronchoscopy with bronchoalveolar lavage
(FOB+BAL) to evaluate for underlying structural anom-
alies, comorbidities, underlying genetic disorders and an
infectious etiology [2,5,6,9,10].
In this report, we describe the findings of FOB+BAL,
in a selected group of young persistent wheezers without
underlying structural anomalies. We focus on the micro-
biological findings and discuss the possible pathophysi-
ology of bronchial bacterial infection.
Methods
Patients
Children with physician diagnosed, persistent wheezing
unresponsive to ICS therapy, who underwent FOB+BAL
between January 2005 and December 2007 were
included. As a tertiary referral centre, we are referred
children for further evaluation and treatment of persist-
ent wheezing despite ICS treatment and anti-reflux ther-
apy in those with demonstrated GERD. Our initial
assessment includes a detailed history of disease, symp-
toms, signs and treatment adherence, a check for the ap-
propriateness of treatment administration and dosage,
and a thorough physical examination. In children with-
out any apparent explanation for persistent wheezing, a
work-up, including FOB+BAL is conducted. In these
cases, FOB+BAL is always performed under stable con-
dition, outside episodes of acute infection or exacerba-
tion of respiratory symptoms.
Children with symptoms other than wheezing, such as
chronic wet cough, recurrent bronchitis and stridor,
being the main reason for FOB+BAL were excluded.
Children with respiratory tract anomalies including
malacia of the conductive airways, or with known under-
lying chronic conditions, such as cystic fibrosis, primary
ciliary dyskinesia, immune deficiency, bronchopulmon-
ary dysplasia, congenital heart diseases and neuromuscu-
lar disorders were also excluded.
When available, results of allergy and reflux testing,
data on anti-reflux therapy prior to FOB+BAL, familial
history of allergy and asthma, a history of exposure to
tobacco smoke, and the response to antibiotic treatment
were recorded. Children with positive skin prick tests
and/or elevated specific immunoglobulin E in blood
were considered allergic. GERD was assessed by a posi-
tive 24 hour-oesophageal pH measurement, interpreted
according to gastroenterological criteria [11].
Flexible fibroscopic bronchoscopy with bronchoalveo-
lar lavage:
FOB and BAL-sampling were performed according to
European Respiratory Society recommendations, as pre-
viously described [12,13]. BAL-samples were divided into2 aliquots, which were immediately sent to the Micro-
biology lab and the Hematology lab.
Laboratory methods
Microbiology
Upon arrival in the lab, BAL-samples were processed for
smear, bacterial culture, viral culture, and for the detec-
tion of influenzavirus A and B; parainfluenzavirus types
1, 2, 3; RSV; human metapneumovirus subtypes A and
B; coronaviruses 229E and OC43, Mycoplasma pneumo-
niae and Chlamydophila pneumoniae using an in-house
multiplex Polymerase Chain Reaction (mPCR)- protocol,
as described previously [13]. The performance of this
test was assessed by regular participation in the external
quality programme organised by QCMD (West of
Scotland Science Park Glasgow G20 0XA Scotland, UK).
Gram staining of smear and bacterial BAL-culture were
performed according to standard methods [14,15]. 70 μL
of BAL-fluid was centrifugated on a cytospin slide and
Gram stained. Samples were considered representative of
the lower airways, if >40 % of instilled volume was recov-
ered and if< 1 % of nucleated cells are squamous epithe-
lial cells on smear. Undiluted and 1 μL of a 1/1000
dilution of BAL-fluid were inoculated on blood agar sup-
plemented with X and V factors incubated at 35 °C in
5 % CO2, MacConkey agar and mannitol salt agar incu-
bated at 35 °C in air. Growth was assessed after 24 h, and
after 48 h in case of no growth at 24 h. Results were
reported in semi-quantitative terms, with a growth of po-
tential pathogens of ≥104 cfu/ml considered significant.
All H. influenzae and S. pneumoniae isolates were sent
to the respective Belgian reference lab for capsular typ-
ing as described elsewhere [13].
All NTHi isolates were discriminated from non-
haemolytic Haemophilus haemolyticus (non-haemolytic
H. haemolyticus) using molecular techniques [13].
Cytology
BAL-fluid was transported to the laboratory in a silico-
nized container on ice. The fluid was filtered through
nylon gauze. After staining with brilliant cresyl blue,
total nuclear cell counts were performed in a Bürker
counting chamber under light microscopy at a magnifi-
cation of 250x. A cell suspension of 2.106 cells/ μl was
made in phosphate-buffered saline with 1 % bovine
serum albumin (PBS-BSA). Cytocentrifuge preparations
were made and stained by May-Grünwald Giemsa. Two
hundred cells were examined for differential cell counts.
Given that the median percentage of neutrophils in
BAL-fluid of healthy children is 0.9-3.5 %, we chose to
base our definition for neutrophilic inflammation in
BAL-fluid on presence of >10 % neutrophils in the cyto-
logical differentiation, as previously done by Saito et al.
[10,12].







Significant BAL-culture 11/33 (33.3) 5/33 (15.2) 16/33 (48.5)
Haemophilus influenzae 6 (18.2)e 4 (12.1)a 10 (30.3)
Streptococcus pneumoniae 1 (3.0)d 3 (9.1) 4 (12.1)
Moraxella catarrhalis 2 (6.1) 2 (6.1)a 4 (12.1)
Staphylococcus aureus 0 1 (3.0)c 1 (3.0)
Escherichia coli 2 (6.1)b 0 2 (6.1)
Serratia marcescens 0 1 (3.0)c 1 (3.0)
Commensal flora 15 (45.4)
< 104 cfu/ml potential
pathogens in BAL
2 (6.1)
Viral infection n (%) 5/32 (15.6) 2/32 (6.3) 7/32 (21.9)
Respiratory syncytial virus 2 a 1b 3
Adenovirus 0 1b 1
Cytomegalovirus 1 0 1
Enterovirus (not polio) 0 1c 1
Coronavirus E229 1d 0 1
Human metapneumovirus 1 0 1




Atypical microorganism positive negative Total
Mycoplasma pneumoniae 1e 18 1/19
Chlamydophila pneumoniae 0 14/14 0/14
Co-infection: cases in which at least 2 infective agents of the same
microbiological group were isolated.
a,b,c,d,e Mixed infections: cases in which at least 2 infective agents of a different
microbiological group were detected. Mixed infections are mentioned for each
pathogen.
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Statistical analyses were performed using SPSS IBM Sta-
tistics version 19 software. Mann-Withney Test was used
for equality of medians, with a 2-tailed p-value< 0.05
considered statistically significant. Multiple comparisons
were handled by the Holm's method.
Ethics
In all cases FOB+BAL was medically indicated. Full par-
ental consent was obtained orally after explanation of
the procedure, its benefits and its risks.
Retrospective chart analysis was approved by the eth-
ical committee of the Universitair Ziekenhuis Brussel
(UZ Brussel).
Results
Thirty-three children, 12 girls and 21 boys with a me-
dian age of 10 months (range 4-38 m), were assessed be-
cause of unexplained persistent wheezing despite ICS
therapy. Administrated ICS dosages ranged from 100–
500 mcg fluticasone daily or equivalent, with a variable
treatment duration of 1–10 months.
Table 1 summarises the characteristics of the study
population with respect to allergy and reflux testing
results, and familial and environmental risk factors for
asthma. Only 7 of 13 (53.8 %) children suffering from
gastro-oesophageal reflux disease (GERD), were treated
for GERD prior to FOB+BAL.
None of the children were treated with antibiotics in
the 7 days prior to FOB+BAL.
The FOB+BAL procedure was well tolerated in all
children.
Significant bacterial cultures were found in 16 of 33
(48.5 %) children (Table 2). No significant differences in
the number of positive BAL-cultures were seen in chil-
dren with or without GERD.
Aerobic bacteria were isolated as sole pathogen in 11
of 33 (33.3 %) cases. Mixed bacterial-viral infection and
mixed bacterial-atypical infection were found in 4 of 33
(12.1 %) and in 1 of 33 (3.0 %) cases, respectively
(Table 2).
Considering only significant bacterial BAL-cultures,
Haemophilus influenzae (H. influenzae), isolated fromTable 1 Patients characteristics: comorbidities, and
familial and environmental risk factors for asthma
Characteristic n = 33 Yes n (%) No n (%) Unknown n (%)
allergy 5 (15.2) 24 (72.7) 4 (12.1 )
GERD 13 (39.4) 15 (45.5) 5 (15.2 )
allergy/ asthma in
first degree relatives
14 (42.4) 12 (36.4) 7 (21.2)
tobacco exposure 3 (9.1) 16 (48.5) 14 (42.4)10 of 33 (30.3 %) children, was the predominant bacteria
found, followed by Streptococcus pneumoniae (S. pneu-
moniae) and Moraxella catarrhalis (M. catarrhalis)
(Table 2). Bacterial co-infection was found in 5 of 33
(15.2 %) cases, including H. influenzae in 4 of these;
twice with S. pneumoniae, once with M. catarrhalis and
once with both S. pneumoniae and M. catarrhalis, and 1
co-infection with Staphylococcus aureus and Serratia
marcescens (Table 2).
Respiratory viruses were detected in 7 of 32 (21.9 %)
cases, with predominance of respiratory syncytial virus
(RSV) (Table 2). In 3 of 32 (9.4 %) cases the respiratory
virus was the sole pathogen detected (Table 2). Myco-
plasma pneumoniae was detected in 1 of 19 cases, in a
mixed infection with H. influenzae (Table 2).
Capsular typing of H. influenzae isolates revealed that
all 10 isolates were non-encapsulated strains (NTHi).
All 10 NTHi strains were evaluated for misidentifica-
tion of non-haemolytic H. haemolyticus, and all were
proven true NTHi. Nine of ten (90 %) NTHI isolates
Table 3 Cytology of BAL in patients with NTHI-isolated





























% 5.5 (3.4-9.0) 6.0 (2.0-10.0) NSa
Eosinophils
cells/mm3 0.0 (0.0-0.0) 0.0 (0.0-0.65) NS













Values are expressed as median (IQR).
* with epithelial cells included.
a adjusted p-values for multiple comparisons by Holm's Method.
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lin (MIC ≤ 1μg/ml) and cefuroxime (MIC ≤ 1μg/ml) [16].
The latter isolate was β-lactamase positive, with a MIC=
2μg/ml for amoxicillin-clavulanate and MIC= 3μg/ml
for cefuroxime.
The 4 S. pneumoniae isolates were fully susceptible to
penicillin and belonged to serogroups; ST 6, ST 9, ST 11
and ST 19.
Susceptibility based antibiotic treatment in patients
with a significant BAL-culture is routine in our centre.
In general, antibiotics are administered orally for 10 days
(daily dose: 50–75 mg/kg for amoxicillin or amoxicillin-
clavulanate). 7 Of 16 (43,8 %) patients responded well to
treatment, in 3 of 16 (18,8 %) no change in symptoms
was noted, and data were missing for 6 patients. In 4 of
7 (57,1 %) responders however, symptoms relapsed
within 2–3 weeks after completion of the antibiotic
treatment. In one of these patients, FOB+BAL was
repeated 70 days after the initial procedure. NTHi (>105
colony forming units (cfu)/ml) that was present as sole
pathogen in the first BAL fluid was cultured again to-
gether with S. pneumoniae (>105 cfu/ml).
The Total cell count (TCC) in BAL-fluid was high
(median: 1055.5/mm3, IQR: 544.5/mm3 - 2099.75/mm3)
and differential cytology revealed a neutrophilic inflam-
mation in 24 of 28 (85.7 %) patients.
Patients with a positive bacterial BAL-culture, had a
significantly higher TTC (median 1893.5/mm3, IQR
829.7/mm3- 3479.5/mm3 versus 787.0/mm3, IQR 283.5/
mm3 - 1439.5/mm3; p = 0.023) compared to patients
with a negative BAL-culture. Cytology of BAL-fluid dif-
fered significantly between patients with NTHi isolated
from BAL and patients with a negative BAL-culture
(Table 3).
Discussion
In contrast to viral infections, which are known to be
associated with wheezing in young children, bacterial
infections have long been considered of no importance
in asthma and wheezing, and antibiotic therapy is not
recommended in current asthma treatment guidelines
[17-20]. However, several studies suggest that bacteria
might play a role in wheezing in young children
[9,10,17,19,20]. Moreover, it is increasingly appreciated
that the human body is home to an extended micro-
biome, with asthmatic children harbouring different bac-
teria and a less diverse mix compared to healthy
children [21]. Characterisation of the predominant bac-
teria in wheezing children is essential to understand the
pathophysiology of persistent wheezing.
Recently, tracheobronchomalacia has been shown to
be highly associated with bronchial inflammation and
bacterial infection in children with persistent respiratory
symptoms [22]. Nevertheless, it remains unclear whetherbacterial infection is simply a consequence of impaired
mucociliary clearance or whether it is an independent
inflammatory stimulus in persistent wheezers.
We hypothesized that bacterial infection might indeed
be an independent inflammatory stimulus in persistent
preschool wheezers, and chose to study a selected group
of patients without structural anomalies of the conduct-
ive airways.
In our study, we found that bronchial bacterial in-
fection is common in persistent preschool wheezers
without apparent reasons for impaired mucociliary
clearance, and that H .influenzae was the predominant
aerobic pathogen isolated, followed by S. pneumoniae
and M. catarrhalis. We also found frequent bacterial
co-infection involving these 3 pathogens. Our find-
ings corroborate observations of other authors, who
also described the predominance of this bacterial triad
in children with persistent or recurrent wheezing
[9,10,19,20,23,24].
The frequent upper respiratory tract colonisation with
these aerobic bacteria in children, may provide difficul-
ties to discriminate between contamination and true
bronchial infection [25]. However, we consider our
results to reflect true bronchial infection, as we applied
procedural methods, which were shown to limit strongly
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we chose to use a cut-off of ≥104 cfu/ml for bacterial
BAL-culture, although in adults a cut-off of ≥103 cfu/ml
has demonstrated to be discriminative [28,29]. The ap-
plied cut-off was also used previously by others, studying
children with chronic bronchitis [30]. Moreover, al-
though FOB+BAL were only performed once in the ma-
jority of patients, our results probably reflect chronic
bronchial infection as all our samples were collected
during stable clinical state.
The presence of a significant increased neutrophilic in-
flammation in BAL-fluid of those patients in which
NTHi was cultured, as compared to patients with a
negative BAL-culture, supports the hypothesis that bac-
terial infection is indeed an inflammatory stimulus in
children with persistent wheezing[24].
H. influenzae was the predominant aerobic bacterial
pathogen, isolated in 30.3 % of our patients. Although
previously other authors have had similar results, iso-
lated strains of H. influenzae were never further charac-
terised [9,10,20,23]. To our knowledge this is the first
report that associates bronchial infection with non-
typeable H. influenzae (NTHi) in young persistant
wheezers. Identification of NTHi as the predominant
pathogen further supports our hypothesis that persistent
wheezers present an underlying inflammation induced
by chronic bacterial infection. Chronic NTHI infection,
resulting from the ability of NTHI to persist in the
lower airways through several escape mechanisms from
the host immune responses, has previously been reported
by others [31-33]. Moreover, in the lower airways of
patients with chronic obstructive lung disease, NTHI
has been demonstrated to be a major inflammatory
stimulus [31,34].
The poor response of symptoms to an in-vitro sus-
ceptibility guided, adequately dosed antibiotic treatment
that we found, is similar to poor response findings in 2
other disease entities involving H. influenzae as a pre-
dominant pathogen in children; recurrent and unre-
sponsive otitis media and protracted bacterial bronchitis
[35-38]. In the middle ear, biofilm formation has been
demonstrated to be one of the major mechanisms for
persistence and provides an explanation for unrespon-
siveness to antibiotic therapy [39,40]. Moreover, biofilm
formation and intracellular infection are well established
mechanisms of NTHi for persistence in the lower air-
ways [31-33]. Although our study does not provide evi-
dence of biofilm formation in the lower airways of
young unresponsive wheezers, our findings of poor re-
sponse to and frequent relapse after a short course of
antibiotic treatment are suggestive for involvement of
biofilm. Biofilm formation should be addressed in future
studies, because its presence may have consequences
for treatment.The strength of our study is the exhaustive microbio-
logical evaluation with use of semi-quantitative BAL-
cultures, multiplex-PCR (mPCR) for viral and atypical
agents, and thorough characterisation of the isolated H.
influenzae strains. However, we may have missed some
cases of viral infection because human rhinovirus was
not included in the applied PCR-protocol.
The major weakness of our study is its retrospective
character and the absence of an age-matched control
group. However, reports, from prospective conducted
studies without profound characterisation of the isolates,
describing association between wheezing and bacterial
infection support our findings [10,19,22]. The absence of
a control group is considered a minor weakness, as pre-
vious publications have demonstrated the limited risk
for contamination of BAL when technical precautions
are taken [13,20,26,27]. Moreover, performance of FOB+
BAL is considered unethical in healthy children [10,12].
Another limitation is the small patient cohort. Due to
the multiple exclusion criteria applied, the patients
included in the analysis represented only 1,2 % of chil-
dren seen in our clinic because of persistent respiratory
symptoms. Nevertheless, analysis of this highly selected
population without structural causes of impaired mucus
clearance, enabled us to evaluate the association between
bacterial bronchial infection, neutrophilic inflammation
and symptoms resistant to ICS therapy.Conclusions
In preschool children with persistent wheezing unre-
sponsive to adequate inhaled asthma treatment, bac-
terial infection is frequent, with NTHi, S. pneumoniae
and M. catarrhalis being the main pathogens involved.
These microbiological findings and the presence of a
pronounced neutrophilic inflammation in BAL-fluid,
sampled in patients not presenting an acute exacerbation
episode, favours the hypothesis that chronic bacterial in-
fection is an ongoing inflammatory stimulus providing a
possible explanation for persistent wheezing despite ICS
therapy in these young patients. These elements suggest
that the use of antibiotic treatment, although not cur-
rently recommended, should be considered in selected
young children presenting with chronic wheezing. How-
ever, as these patients are indistinguishable without the
use of invasive procedures, and biofilm formation and
other escape mechanisms may decrease the bactericidal
efficacy of antibiotic treatment, additional research is ne-
cessary before specific treatment recommendations can
be provided. Future research should focus on popula-
tion characteristics, determination of risk factors for ac-
quisition of bacterial bronchial infection, pathogenicity
mechanisms of chronic bronchial infection and possible
prevention and treatment strategies.
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